Med Renal 2020 Explanation

May 9, 2026

A clinical follow-up case addresses renovascular hypertension caused by severe atherosclerotic renal artery stenosis (80%) in a man with longstanding risk factors including type 2 diabetes, hyperlipidemia, obesity, and diffuse atherosclerosis requiring prior peripheral vascular stenting. The explanation links reduced post-stenotic renal perfusion to activation of the renin-angiotensin-aldosterone system and maladaptive sodium retention, volume expansion, vasoconstriction, and elevated blood pressure. It states ACE inhibitors or ARBs are first-line therapy, with close monitoring for acute kidney injury, and emphasizes risk-factor control while clarifying that loop diuretics and doxazosin are not preferred, and revascularization is not routinely superior to medical management.

Share with

May 9, 2026